Publications

5803 Results

Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21

Authors
M Zhang;Z Wang;O Obazee;J Jia;E Childs;J Hoskins;G Figlioli;E Mocci;I Collins;CC Chung;C Hautman;A Arslan;L Beane-Freeman;P Bracci;J Buring;EJ Duell;S Gallinger;GG Giles;GE Goodman;P Goodman;A Kamineni;L Kolonel;MH Kulke;N Malats;S Olson;H Sesso;K Visvanathan;E White;W Zheng;CC Abnet;G Andreotti;M Austin;H Bueno-de-Mesquita;D Basso;M Boutron-Ruault;M Bijlsma;H Brenner;L Burdette;D Campa;N Caporaso;G Capurso;G Cavestro;C Cotterchio;E Costello;J Elena;U Boggi;J Gaziano;EL Giovannucci;M Goggins;M Gorman;M Grosse;C Haiman;M Hassan;K Helzlsouer;N Hu;D Hunter;EIskierka-Jazdzewska;M Jenab;R Kaaks;T Key;K Khaw;EA Klein;M Kogevinas;V Krogh;J Kupcinskas;R Kurtz;M Landi;S Landi;L Le Marchand;A Mambrini;S Mannisto;R Milne;R Neale;A Oberg;S Panico;A Patel;P Peeters;U Peters;R Pezzilli;F Tavano;M Porta;M Purdue;J Quiros;E Riboli;N Rothman;A Scarpa;G Scelo;X Shu;D Silverman;P Soucek;O Strobel;M Sund;E Malecka-Panas;P Taylor;R Travis;M Thornquist;A Tjonneland;J Tobias;D Trichopoulos
Journal / Conference
Oncotarget 2016 Oct 11;7(41):66328-66343; 2016 Aug 1[Epub ahead of print]
Year
2016
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID27579533
PMC
PMC5340084
Study Number(s)
S0000

Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin Lymphoma (HL): a sub-analysis of SWOG S0816 phase 2 trial

Authors
A Danilov;H Li;O Press;I Shapira;L Swinnen;A Noy;E Reid;S Smith;J Friedberg
Journal / Conference
Leukemia & Lymphoma Feb;58(2):461-465; 2016 Jul 7:1-5. [Epub ahead of print] [print in 2017]
Year
2016
Research Committee(s)
Lymphoma
PMID
PMID27386786
PMC
PMC5130311
Study Number(s)
S0816

Integrating traditional Electronic Data Capture (EDC) with new systems

Authors
C Cook;T Phillips;M Leblanc
Journal / Conference
Society for Clinical Trials (May 15-18, 2016, Montreal,Quebec, Canada), poster
Year
2016
Research Committee(s)
Lung and Melanoma
Study Number(s)
S1400, S1404

Impact of platinum-sensitivity status on post-progression survival (PPS) of patients with extensive stage small cell lung cancer (ES-SCLC): results from SWOG 0124, a phase III trial of irinotecan/cisplatin(IP) vs. etoposide/cisplatin(EP)

Authors
P Lara;J Miao;J Moon;M Redman;D Gandara;K Kelly
Journal / Conference
World Lung Cancer Conference (Dec 4-7, 2016,Vienna, Austria); oral MA11.06
Year
2016
Research Committee(s)
Lung
Study Number(s)
S0124

Predictors of recurrence during years 5-14 in 46,138 women with ER+ breast cancer allocated 5 years only of endocrine therapy (ET)

Authors
H Pan;R Gray;C Davies;J Bergh;K Pritchard;M Dowsett;DF Hayes
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl; abstr 505); American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), oral
Year
2016
Research Committee(s)
Breast
Study Number(s)
SWOG-8814, SWOG-8897

OV21/PETROC: A randomized Gynecologic Cancer Intergroup (GCIG) phase II study of intraperitoneal (IP) versus intravenous (IV) chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer (EOC)

Authors
H Mackay;CJ Gallagher;W Parulekar;JA Ledermann;D Armstrong;C Gourley;I Romero;A Feeney;P Bessette;M Hall;JI Weberpals;G Hall;S Lau;P Gauthier;M Fung-Kee-Fung;E Eisenhauer;C Winch;D Tu;D Provencher
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl; abstr LBA5503);American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), oral
Year
2016
Research Committee(s)
Gynecologic
Study Number(s)
OV21

A Genetic Contribution to Prostate Cancer Incidence in Men of African Ancestry

Authors
CA Haiman;DV Conti;ELLIPSE GAME-ON Consortium
Journal / Conference
American Society of Human Genetics Meeting (Oct 18-22, 2016, Vancouver, BC), poster presentation
Year
2016
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217

Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer

Authors
M Tanioka;C Fan;LA Carey;T Hyslop;B Pitcher;J Parker;K Hoadley;NL Henry;S Tolaney;C Dang;IE Krop;L Harris;DA Berry;E Mardis;E Winer;CA Hudis
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 6-10, 2016, San Antonio, TX), oral, #S3-05
Year
2016
Research Committee(s)
Breast

US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL

Authors
F Ravandi;M Othus;S O'Brien;SJ Forman;C Ha;JYC Wong;M Tallman;E Paietta;J Racevskis;J Uy;M Horowitz;N Takebe;RF Little;UM Borate;P Kebriaei;L Kingsbury;H Kantarjian;J Radich;H Erba;F Appelbaum
Journal / Conference
Blood Advances Dec 1(3):250-259
Year
2016
Research Committee(s)
Leukemia
PMID
PMID29046900
PMC
PMC5642915
Study Number(s)
S0805

Long term efficacy and QOL data of chemohormonal therapy (C-HT) in low and high volume hormone naïve metastatic prostate cancer (PrCa): E3805 CHAARTED trial

Authors
C Sweeney;Y-H Chen;G Liu;M Carducci;D Jarrard;M Eisenberger;Y Wong;L Patrick-Miller;N Hahn;M Kohli;M Conney;R Dreicer;N Vogelzang;J Picus;D Shevrin;M Hussain;J Garcia;R Dipaola
Journal / Conference
Annals of Oncology vol. 27, 2016 Supp 6,abst. 720PD; European Society for Medical Oncology (October 7-11, 2016, Copenhagen, Denmark), (Annals of Oncology), poster
Year
2016
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/E3805